BBIO EPS Estimates
BridgeBio Pharma, Inc.
$67.16
+$2.22(+3.42%)
36
Overall
40
Value
18
Tech
52
Quality
Market Cap
$12.69B
Volume
966.74K
52W Range
$52.75 - $93.42
Target Price
$108.35
BBIO EPS estimates: the consensus estimate for BridgeBio Pharma, Inc.'s current fiscal year is -$2.66 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BBIO EPS Estimates
- EPS estimate, current quarter
- $-0.67
- EPS estimate, next quarter
- $-0.48
- EPS estimate, current year
- $-2.66
- EPS estimate, next year
- $-0.35
- EPS growth, 3-year
- -5.06%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.78 |
| 2024 | $-2.88 |
| 2023 | $-3.95 |
| 2022 | $-3.26 |
| 2021 | $-3.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $67.16 | +3.4% | 966.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |